Indeed, high levels of Plexin-B1 expression predict longer overall survival in bladder carcinoma, head and neck squamous cell carcinoma, and kidney papillary renal cell carcinoma but shorter overall survival in thymoma and kidney renal clear-cell carcinoma (data from Kaplan-Meier Plotter Pan-Cancer Tool; https://kmplot.com/analysis/index.php?p=back ground; ref. 55). Here, PLXNB1 is linked to head and neck squamous cell carcinoma.